series-a
Stage
2017
Founded
2
Investors
About
Develops therapeutics focused on regulatory elements of the non-coding genome to create new disease treatments.
Explore Nucleome Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.